Cargando…
Incorporating lesion-to-lesion heterogeneity into early oncology decision making
RECISTv1.1 (Response Evaluation Criteria In Solid Tumors) is the most commonly used response grading criteria in early oncology trials. In this perspective, we argue that RECISTv1.1 is ambiguous regarding lesion-to-lesion variation that can introduce bias in decision making. We show theoretical exam...
Autores principales: | Kumar, Rukmini, Qi, Timothy, Cao, Yanguang, Topp, Brian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10282604/ https://www.ncbi.nlm.nih.gov/pubmed/37350966 http://dx.doi.org/10.3389/fimmu.2023.1173546 |
Ejemplares similares
-
Intratumor Heterogeneity of HLA-G Expression in Cancer Lesions
por: Zhang, Xia, et al.
Publicado: (2020) -
Beyond the single average tumor: Understanding IO combinations using a clinical QSP model that incorporates heterogeneity in patient response
por: Kumar, Rukmini, et al.
Publicado: (2021) -
Interstitial Lung Disease in Connective Tissue Disease: A Common Lesion With Heterogeneous Mechanisms and Treatment Considerations
por: Shao, Tihong, et al.
Publicado: (2021) -
Intercepting Premalignant, Preinvasive Breast Lesions Through Vaccination
por: Zachariah, Nadia Nocera, et al.
Publicado: (2021) -
Neuroimaging and clinicopathological differences between tumefactive demyelinating lesions and sentinel lesions of primary central nervous system lymphoma
por: Sun, Chenjing, et al.
Publicado: (2022)